Novo Nordisk spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of ...

While early, the results indicate drugs known as ITK inhibitors have the potential to match or surpass the efficacy observed with the injectable biologic Dupixent.

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Manufacturer Novo Nordisk has partnered with telehealth companies and other weight-loss groups to increase access to the pill, starting at $149 a month Novo Nordisk/FDA The Wegovy pill, which is ...

The Wegovy pill launched Monday, and the starting dose is now available at pharmacies around the country with higher doses arriving by the end of the week. The Food and Drug Administration approved ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Americans can now purchase a starter dose of Novo Nordisk’s weight loss drug Wegovy in pill form, the company announced Monday, pledging widespread availability. The 1.5 milligram starter dose of a ...

Weight-loss drug Wegovy is now available in the form of a pill in the United States, the Scandinavian drug-maker Novo Nordisk announced on Monday, Jan. 5. The first-of-its kind pill offers 1.5 and 4 ...

The Wegovy pill is the first and only oral GLP-1 for weight loss in adults. The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced ...

DURHAM, N.C. (WTVD) -- A popular weight loss drug made in the Triangle is now available in pill form. On Monday, pharmaceutical company Novo Nordisk announced FDA approval of a new Wegovy pill, the ...

The new Wegovy pill was just approved in the US—and it’s the first oral GLP-1 for weight management on the market. Trials suggest it’s approximately as effective as the injectable form, and it has ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...